SCHEMBL31700720

SCHEMBL31700720

CNc1cc[nH]c(=O)c1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
POLB P06746 1/20 0.35
ATM Q13315 1/20 0.35
CHEK1 O14757 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
ALPL P05186 1/20 0.32
BRD4 O60885 2/20 0.31
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
JAK2 O60674 1/20 0.31
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31
TUBA3E Q6PEY2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31701620 0.74 CYP1A2 (0.35) KDM4ECHEK1ALDH1A1JAK2PARP1
SCHEMBL18152647 0.74 CYP19A1 (0.35) KDM4EPOLBL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL31701724 0.72 PARP1 (0.33) CHEK1JAK2PARP1PDPK1
SCHEMBL27298899 0.68 JAK2 (0.39) KDM4EALDH1A1SMN1; SMN2JAK2PARP1
SCHEMBL22216142 0.68 TSHR (0.33)
SCHEMBL14848190 0.68 NAPRT (0.48) KDM4EPOLBL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL10094591 0.67
SCHEMBL7413081 0.67 PDPK1 (0.39) CHEK1L3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL14829330 0.66 ALDH1A1 (0.52) KDM4EPOLBL3MBTL1ALDH1A1JAK2
SCHEMBL22146244 0.64 JAK2 (0.37) CHEK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001893-A1 SMALL MOLECULE MODULATORS OF STAT6 GILEAD SCIENCES INC (US) 2026-01-01 US disclosed
US-20250320205-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed
US-20250320206-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001893-A1 SMALL MOLECULE MODULATORS OF STAT6 STAT6, NCOR1, NCOR2 KDM4E 1055/4885POLB 4096/4885ATM 1851/4885
US-20250320205-A1 STAT6 DEGRADERS STAT6, STAT1, STAT5B KDM4E 141/4885POLB 3072/4885ATM 1082/4885
US-20250320206-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 KDM4E 167/4885POLB 3003/4885ATM 1026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.